A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers

NACompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

May 24, 2018

Primary Completion Date

March 24, 2021

Study Completion Date

April 5, 2021

Conditions
Palpable Breast Cancer
Interventions
DEVICE

Breast Cancer Locator (BCL)

This locator will be constructed pre-operatively, sterilized and provided to the surgeon at the time of procedure. The outline of the breast cancer on the breast surface at the point where the cancer is closest to the skin is built into the locator, so that the surgeon can simply apply the locator to the patient's breast and trace the tumor outline on the skin.

Trial Locations (4)

01805

Lahey Hospital & Medical Center (Lahey Clinic), Burlington

03431

Cheshire Medical Center, Keene

03756

Dartmouth Hitchcock Medical Center, Lebanon

03060

St. Joseph Hospital, Nashua

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT03573661 - A Pilot Multi-Institutional Study to Evaluate the Accuracy of a Breast Cancer Locator in Patients With Palpable Cancers | Biotech Hunter | Biotech Hunter